Kerry Group adds Michael Kerr to its Board as Non-Executive Director and announces Dr. Hugh Brady as Senior Independent Director

– IRELAND, Tralee –  Kerry Group plc (LON: KYGA | OTC: KRYAF) today announced the appointment of Michael Kerr to its Board as a non-executive director with effect from 3 May 2021.

Ms. Joan Garahy retired from the Board of Directors effective today and will be succeeded by Dr. Hugh Brady as Senior Independent Director and by Tom Moran as Chair of the Remuneration Committee with effect from 29 April 2021.

“On behalf of the Group we are delighted that Michael will be joining our Board. His addition brings significant and wide-ranging business leadership and experience across global capital markets, and in particular U.S. markets, which will further strengthen the broad range of skills and experience on Kerry’s Board” said Board Chairman, Philip Toomey.

He added: “I would like to thank Joan sincerely for her outstanding dedication and contribution to the Group over the last nine years. Joan was an exceptional non-executive director and we wish her the very best in her future endeavors”. 

About Michael Kerr

Mr. Kerr has over 36 years of investment management experience having retired after a long and successful career with Capital Group, one of the world’s oldest and largest investment management organizations. He will bring to the Board a detailed knowledge of global equity capital markets, extensive business leadership skills, and insights into the North American market.

Mr. Kerr is currently a non-executive director with EOG Resources Inc, which is listed on the New York Stock Exchange.

For more information: https://www.kerrygroup.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.